IMMX
Income statement / Annual
Last year (2024), Immix Biopharma, Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2024, Immix Biopharma, Inc.'s net income was -$21.61 M.
See Immix Biopharma, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
| Operating Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
| Research and Development Expenses |
$11.29 M
|
$8.74 M
|
$4.20 M
|
$126.53 K
|
$248.15 K
|
$583.16 K
|
| General & Administrative Expenses |
$11.38 M
|
$7.41 M
|
$4.02 M
|
$1.23 M
|
$205.70 K
|
$259.34 K
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$11.38 M
|
$7.41 M
|
$4.02 M
|
$1.23 M
|
$205.70 K
|
$259.34 K
|
| Other Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
-$0.00
|
$0.00
|
| Operating Expenses |
$22.67 M
|
$16.14 M
|
$8.22 M
|
$1.35 M
|
$453.85 K
|
$842.50 K
|
| Cost And Expenses |
$22.67 M
|
$16.14 M
|
$8.22 M
|
$1.35 M
|
$453.85 K
|
$842.50 K
|
| Interest Income |
$1.02 M
|
$572.01 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$0.00
|
$0.00
|
$497.00
|
$179.85 K
|
$101.98 K
|
$109.98 K
|
| Depreciation & Amortization |
$115.39 K
|
$5.47 K
|
$2.14 K
|
$2.47 K
|
$2.32 K
|
$1.08 K
|
| EBITDA |
-$22.56 M |
-$16.14 M |
-$8.22 M |
-$24.20 M |
-$451.53 K |
-$841.42 K |
| EBITDA Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
| Operating Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
$1.02 M
|
$572.01 K
|
-$497.00
|
-$23.03 M
|
-$676.46 K
|
-$109.76 K
|
| Income Before Tax |
-$21.66 M
|
-$15.57 M
|
-$8.22 M
|
-$24.38 M
|
-$1.13 M
|
-$952.26 K
|
| Income Before Tax Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$41.04 K
|
$26.42 K
|
$10.27 K
|
$6.01 K
|
$17.55 K
|
$20.55 K
|
| Net Income |
-$21.61 M
|
-$15.43 M
|
-$8.23 M
|
-$24.38 M
|
-$1.15 M
|
-$972.81 K
|
| Net Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
| EPS |
-0.76 |
-0.89 |
-0.59 |
-6.64 |
-0.15 |
-0.29 |
| EPS Diluted |
-0.76 |
-0.89 |
-0.59 |
-6.64 |
-0.15 |
-0.29 |
| Weighted Average Shares Out |
$28.29 M
|
$17.34 M
|
$13.89 M
|
$3.67 M
|
$7.77 M
|
$3.38 M
|
| Weighted Average Shares Out Diluted |
$28.29 M
|
$17.34 M
|
$13.89 M
|
$3.67 M
|
$7.77 M
|
$3.38 M
|
| Link |
|
|
|
|
|
|
